3 unchanged sentences
001-38693), filed with the SEC on October 15, 2018).
+Added: 3.2 Certificate of Amendment of Amended and Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-38693), filed with the SEC on June 17, 2022)
3.3 Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K (File No.
5 unchanged sentences
333-227333), filed with the SEC on September 14, 2018).
+Added: 10.1 First Amendment to the Share Purchase Agreement, dated May 11, 2022, by and among the Registrant, Overland Pharmaceuticals (CY) Inc.
+Added: and Allogene Overland Biopharm (CY) Limited.
31.1 Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.
10 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: May 4, 2022 By:
+Added: August 9, 2022 By:
/s/ David Chang
2 unchanged sentences
(Principal Executive Officer)
−Removed: May 4, 2022 By:
+Added: August 9, 2022 By:
/s/ Eric Schmidt
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.